Cyclin D3 protein content in human renal cell carcinoma in relation to cyclin D1 and clinico-pathological parameters

被引:37
|
作者
Hedberg, Y
Roos, G
Ljungberg, B
Landberg, G [1 ]
机构
[1] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Div Pathol, SE-20502 Malmo, Sweden
[2] Umea Univ, Dept Med Biosci Pathol, Umea, Sweden
[3] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden
关键词
D O I
10.1080/028418602753669562
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aberrations in the G1/S checkpoint are common in malignancies and are probably important for tumor development. Few G1/S studies have been performed on renal cell carcinoma (RCC) and therefore in this study the cyclin D3 protein content in 80 RCCs and that in 12 corresponding normal kidney cortex tissues are characterized using Western blotting. High cyclin D3 protein content was observed in 16% of the tumors and was significantly associated with aneuploidy, high TNM stage, high nuclear grade, high proliferation and young age. There was no association between tumor cyclin D3 and patient survival. The cyclin D3 overexpression was confirmed by immunohistochemical staining of 72 tumors, showing both nuclear and cytoplasmic localization of cyclin D3 in a fraction of the tumors. The cyclin D1 content has earlier been characterized in this tumor material and there was no relation between cyclin D1 and cyclin D3 protein expression. In summary, a fraction of the tumors overexpressed cyclin D3, supporting that various aberrations in the G1/S transition are implicated in RCCs.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 50 条
  • [41] Reciprocal expressions of cyclin E and cyclin D1 in hepatocellular carcinoma
    Jung, YJ
    Lee, KH
    Choi, DW
    Han, CJ
    Jeong, SH
    Kim, KC
    Oh, JW
    Park, TK
    Kim, CM
    CANCER LETTERS, 2001, 168 (01) : 57 - 63
  • [42] Prognostic utility of cyclin D3, cyclin E, P27, MUC1 in renal cell carcinoma (RCC)
    Kiremitci, Saba
    Tulunay, Ozden
    Baltaci, Sumer
    Gogus, Orhan
    VIRCHOWS ARCHIV, 2007, 451 (02) : 153 - 154
  • [43] Role of cyclin D1 in breast carcinoma
    Mohammadizadeh, Fereshteh
    Hani, Mohsen
    Ranaee, Mohammad
    Bagheri, Marzie
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2013, 18 (12): : 1021 - 1025
  • [44] Cyclin D1 overexpression in hepatocellular carcinoma
    Joo, M
    Kang, YK
    Kim, MR
    Lee, HK
    Jang, JJ
    LIVER, 2001, 21 (02): : 89 - 95
  • [45] Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1
    Lahti, JM
    Li, HM
    Kidd, VJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (16) : 10859 - 10869
  • [46] CYCLIN D2 (BUT NOT CYCLIN D1 AND D3) IS EXPRESSED IN LYMPHOCYTES FROM PATIENTS WITH CHRONIC B-CELL LYMPHOID MALIGNANCIES
    DELMER, A
    AJCHENBAUMCYMBALISTA, F
    TANG, RP
    MARIE, JP
    GRIFFIN, JD
    ZITTOUN, R
    BLOOD, 1993, 82 (10) : A201 - A201
  • [47] Cyclin D1 expression in prostate carcinoma
    Pereira, R. A.
    Ravinal, R. C.
    Costa, R. S.
    Lima, M. S.
    Tucci, S.
    Muglia, V. F.
    Dos Reis, R. B.
    Silva, G. E. B.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2014, 47 (06) : 515 - 521
  • [48] Diagnostic and prognostic utility of cyclin D1, cyclin D3, cyclin E, P27, MUC1, CD44, CK7 and CK20 in renal cell carcinoma
    Kiremichi, S.
    Tulunay, O.
    Baltaci, S.
    Gogus, O.
    MODERN PATHOLOGY, 2007, 20 : 156A - 156A
  • [49] Diagnostic and prognostic utility of cyclin D1, cyclin D3, cyclin E, p27, MUC1, CD44, CK7 and CK20 in renal cell carcinoma
    Kiremitci, S.
    Tulunay, O.
    Baltaci, S.
    Gogus, O.
    LABORATORY INVESTIGATION, 2007, 87 : 156A - 156A
  • [50] Demonstration of cyclin (D1, E) and RB protein expression in human esophageal squamous cell carcinoma
    Ishikawa, T
    Furihata, M
    Inoue, A
    Murakami, H
    Ogoshi, S
    Ohtsuki, Y
    RECENT ADVANCES IN GASTROENTEROLOGICAL CARCINOGENESIS I, 1996, : 377 - 381